Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1873835 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $8.17Day −3.20%Mkt cap $445M1Y +202.6%Off 52W high −32.7%Vol (1Y) 87.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,151 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest15.6% of sh out |
| Days to cover4.6d |
| 13F net flow (QoQ)+5.49% |
| Top-10 13F concentration74.4% |
| Next report (est.)2026-08-07 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$35.0M |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+56.2% |
| 1Y+202.6% |
| 3Y+296.6% |
| Since incept. (ann.)+16.7% |
Total return through 2026-07-29 · series begins 2021-12-17. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)87.4% |
| Ann. volatility (3Y)97.3% |
| Sharpe (1Y)1.71 |
| Sharpe (3Y)0.95 |
| Max drawdown (1Y)−39.8% |
| Max drawdown (3Y)−81.6% |
| Beta (3Y vs SPY)0.06 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 4.8M | $44M | 9.07% | +22.5% |
| Saturn V Capital Management LP | 3.7M | $34M | 6.97% | +23.2% |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.5M | $23M | 4.81% | +0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.8M | $16M | 3.38% | new |
| MILLENNIUM MANAGEMENT LLC | 1.8M | $16M | 3.30% | +5.4% |
| MARSHALL WACE, LLP | 1.6M | $15M | 3.10% | −17.0% |
| Logos Global Management LP | 1.2M | $11M | 2.31% | +22.5% |
| Bleichroeder LP | 1.0M | $9M | 1.89% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.18 | — | — | — |
| 2025-09-30 | 2025-11-07 | −$0.24 | — | — | — |
| 2025-06-30 | 2025-08-08 | −$0.22 | — | — | — |
| 2025-03-31 | 2025-05-08 | −$0.15 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-07 is ESTIMATED from filing cadence (median gap 92d) — not company-confirmed.
